Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
Abstract Bacterial vaginosis (BV), characterized by an imbalance in the vaginal microbiota, is a prevalent condition among women of reproductive age and a risk factor for human immunodeficiency virus, sexually transmitted infections, and preterm birth. BV is generally considered to induce mucosal in...
Saved in:
Main Authors: | Philipp Foessleitner, Briah Cooley Demidkina, Wafae El-Arar, Miles Goldenberg, Meena Murthy, Agnes Bergerat, Ofri Bar, Douglas S. Kwon, Caroline M. Mitchell |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88208-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OPTIMIZATION OF ANTIBACTERIAL THERAPY FOR NONSPECIFIC VAGINITIS IN WOMEN OF REPRODUCTIVE AGE
by: O. D. Ryazanova, et al.
Published: (2022-09-01) -
The effectiveness of complex therapy in the treatment of nonspecific vaginitis in women of reproductive age
by: O.D. Ryazanova, et al.
Published: (2022-12-01) -
Hormonal status in women of reproductive age with nonspecific vaginitis
by: O.D. Ryazanova
Published: (2023-03-01) -
Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study
by: Fiona Tidbury, et al.
Published: (2025-01-01) -
Dynamics and diversity of vaginal microbiota in bacterial vaginosis among Thai patients treated with metronidazole
by: Auttawit Sirichoat, et al.
Published: (2025-02-01)